Direct head-to-head comparisons of ARBs vs. ACE-Is have been limited, but studies have associated ARB use with less brain atrophy [25, 26], lower dementia incidence [23, 27–29], and slower cognitive decline [25, 30, 31] relative to ACE-I use. The gene discussed is ACE; the disease is Mental deterioration.